Skip to main content

Advertisement

Log in

Analysis of seven prognostic scores in patients with surgically treated epidural metastatic spine disease

  • Original Article - Spine - Other
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Prognostic scores have been proposed to guide the treatment of patients with metastatic spine disease (MSD), but their accuracy and usefulness are controversial. The aim of this study was to evaluate seven such prognostic scoring systems. The following prognostic scores were compared: Tomita, Van der Linden (VDL), Bauer modified (BM), Oswestry Spinal Risk Index (OSRI), Tokuhashi original (T90), Tokuhashi revised (TR05), and modified Tokuhashi revised (TR17).

Methods

We retrospectively reviewed all our patients who underwent surgery for spinal metastases, February 2008–January 2015. We classified all 223 patients into the predicted survival-time categories of each of the 7 scoring systems and then tallied how often this was correct vis-à-vis the actual survival time. Accuracy was also assessed using receiver operating characteristic (ROC) analysis at 1, 3, and 12 months.

Results

The median (95% CI) survival of the 223 patients was 13.6 (7.9–19.3) months. A groupwise ROC analysis showed sufficient accuracy for 3-month survival only for TR17 (area under the curve [AUC] 0.71) and for 1-year survival for T90 (AUC 0.73), TR05 (AUC 0.76), TR17 (AUC 0.76), Tomita (AUC 0.77), and OSRI (AUC 0.71). A pointwise ROC score analysis showed poor prognostic ability for short-term survival (1 and 3 months) with sufficient accuracy for T90 (AUC 0.71), TR05 (AUC 0.71), TR17 (AUC 0.71), and the Tomita score (AUC 0.77) for 1-year survival.

Conclusion

The TR17 was the only prognostic system with acceptable performance here. More sophisticated assessment tools are required to keep up with present and future changes in tumor diagnostics and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ahmed AK, Goodwin CR, Heravi A, Kim R, Abu-Bonsrah N, Sankey E, Kerekes D, De la Garza RR, Schwab J, Sciubba DM (2018) Predicting survival for metastatic spine disease: a comparison of nine scoring systems. Spine J. https://doi.org/10.1016/j.spinee.2018.03.011

    Article  Google Scholar 

  2. Balain B, Jaiswal A, Trivedi JM, Eisenstein SM, Kuiper JH, Jaffray DC (2013) The Oswestry Risk Index. Bone Joint J 95-B(2):210–216

    Article  CAS  Google Scholar 

  3. Brookmeyer R, Crowley J (1982) A confidence interval for the median survival time. Biometrics. https://doi.org/10.2307/2530286

    Article  Google Scholar 

  4. Cassidy JT, Baker JF, Lenehan B (2018) The role of prognostic scoring systems in assessing surgical candidacy for patients with vertebral metastasis: a narrative review. Glob Spine J. https://doi.org/10.1177/2192568217750125

    Article  Google Scholar 

  5. Coleman RE, Roodman, Smith, Body, Suva, Vessella (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res doi: https://doi.org/10.1158/1078-0432.CCR-06-0931

    Article  Google Scholar 

  6. Doherty GJ, Petruzzelli M, Beddowes E, Ahmad SS, Caldas C, Gilbertson RJ (2019) Cancer treatment in the genomic era. Annu Rev Biochem. https://doi.org/10.1146/annurev-biochem-062917-011840

    Article  CAS  Google Scholar 

  7. Forsberg JA, Wedin R, Bauer HCF, Hansen BH, Laitinen M, Trovik CS, Keller JT, Boland PJ, Healey JH (2012) External validation of the Bayesian Estimated Tools for Survival (BETS) models in patients with surgically treated skeletal metastases. BMC Cancer. https://doi.org/10.1186/1471-2407-12-493

  8. Greenwood M (1926) The natural duration of cancer. Reports Public Heal. Med. Subj. 33, London Her Majesty’s Station. Off, pp 1–26

  9. Hernandez RK, Wade SW, Reich A, Pirolli M, Liede A, Lyman GH (2018) Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer. https://doi.org/10.1186/s12885-017-3922-0

  10. Hyman DM, Piha-Paul SA, Won H et al (2018) HER kinase inhibition in patients with HER2-and HER3-mutant cancers. Nature. https://doi.org/10.1038/nature25475

    Article  CAS  Google Scholar 

  11. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc. https://doi.org/10.1080/01621459.1958.10501452

    Article  Google Scholar 

  12. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH (1948) The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer. https://doi.org/10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L

  13. Kataoka M, Kunisada T, Tanaka M, Takeda K, Itani S, Sugimoto Y, Misawa H, Senda M, Nakahara S, Ozaki T (2012) Statistical analysis of prognostic factors for survival in patients with spinal metastasis. Acta Med Okayama 66(3):213–219

    PubMed  Google Scholar 

  14. Lee YT, Tan YJ, Oon CE (2018) Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. https://doi.org/10.1016/j.ejphar.2018.07.034

    Article  CAS  Google Scholar 

  15. Leithner A, Radl R, Gruber G, Hochegger M, Leithner K, Welkerling H, Rehak P, Windhager R (2008) Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J. https://doi.org/10.1007/s00586-008-0763-1

    Article  Google Scholar 

  16. Mizumoto M, Harada H, Asakura H et al (2011) Radiotherapy for patients with metastases to the spinal column: a review of 603 patients at shizuoka cancer center hospital. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2009.10.056

    Article  Google Scholar 

  17. Mo H-N, Liu P (2017) Targeting MET in cancer therapy. Chron Dis Transl Med. https://doi.org/10.1016/j.cdtm.2017.06.002

    Article  Google Scholar 

  18. Morgen SS, Fruergaard S, Gehrchen M, Bjørck S, Engelholm SA, Dahl B (2018) A revision of the Tokuhashi revised score improves the prognostic ability in patients with metastatic spinal cord compression. J Cancer Res Clin Oncol. https://doi.org/10.1007/s00432-017-2519-y

    Article  Google Scholar 

  19. Ortiz Gómez JA (1995) The incidence of vertebral body metastases. Int Orthop. https://doi.org/10.1007/BF00181116

  20. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. https://doi.org/10.1016/S0140-6736(05)66954-1

    Article  Google Scholar 

  21. Pereira NRP, Janssen SJ, Van Dijk E, Harris MB, Hornicek FJ, Ferrone ML, Schwab JH (2016) Development of a prognostic survival algorithm for patients with metastatic spine disease. J Bone Joint Surg Am 98(21):1767–1776

    Article  Google Scholar 

  22. Rosell R, Carcereny E, Gervais R et al (2012) Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol. https://doi.org/10.1016/S1470-2045(11)70393-X

    Article  CAS  Google Scholar 

  23. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976). https://doi.org/10.1097/01.brs.0000180401.06919.a5

    Article  Google Scholar 

  24. Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S (1990) Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976). https://doi.org/10.1097/00007632-199011010-00005

    Article  CAS  Google Scholar 

  25. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T (2001) Surgical strategy for spinal metastases. Spine (Phila Pa 1976). https://doi.org/10.1097/00007632-200102010-00016

    Article  CAS  Google Scholar 

  26. Van YM, Dijkstra SPDS, Vonk EJA, Marijnen CAM, Leer JWH (2005) Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer. https://doi.org/10.1002/cncr.20756

    Article  Google Scholar 

  27. Wibmer C, Leithner A, Hofmann G, Clar H, Kapitan M, Berghold A, Windhager R (2011) Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems. Spine (Phila Pa 1976). https://doi.org/10.1097/BRS.0b013e3182011f84

    Article  Google Scholar 

  28. Yoshihara H, Yoneoka D (2014) Trends in the surgical treatment for spinal metastasis and the in-hospital patient outcomes in the United States from 2000 to 2009. Spine J. https://doi.org/10.1016/j.spinee.2013.11.029

    Article  Google Scholar 

  29. Zoccali C, Skoch J, Walter CM, Torabi M, Borgstrom M, Baaj AA (2016) The Tokuhashi score: effectiveness and pitfalls. Eur Spine J. https://doi.org/10.1007/s00586-015-4339-6

    Article  Google Scholar 

Download references

Acknowledgments

We thank Karim Heinlein (Centre of Orthopedic and Trauma Surgery, University Hospital, Cologne, Germany) for helping us with the management of data, and we would like to thank Angela Ernst, M.Sc., (Institute of Medical Statistics and Computational Biology, Faculty of Medicine, University of Cologne, Germany) for her invaluable help with the graphing options. We would also like to thank Michael Hanna, PhD, (Mercury Medical Research & Writing) for contributing to the revision of the manuscript after the initial journal review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alain Christoph Olivier.

Ethics declarations

This article does not contain any studies with human participants performed by any of the authors.

Disclosures

All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

Ethics

For this type of study, formal consent is not required.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Spine - Other

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Westermann, L., Olivier, A.C., Samel, C. et al. Analysis of seven prognostic scores in patients with surgically treated epidural metastatic spine disease. Acta Neurochir 162, 109–119 (2020). https://doi.org/10.1007/s00701-019-04115-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-019-04115-9

Keywords

Navigation